Page 241 - Health Medical Pharma
Dr. Reddy's Labs spurts after favorable US court ruling
Dr. Reddy's Laboratories rose 7.46% to Rs 2633 at 9:18 IST on BSE after the company announced favorable outcome in Buprenorphine and Naloxone Sublingual Film patent litigation.
Dr. Reddy's Laboratories gets favourable decision in patent litigation in US court
Powered by Capital Market - Live News
Mylan recalls batches of blood pressure medicine in U.S.
(Reuters) - Mylan NV said on Tuesday it would recall certain batches of blood pressure medicine valsartan in the United States after they were found to contain a probable cancer-causing impurity, the latest recall amid heightened safety concerns globally.
U.S. court allows generic version of Indivior opioid abuse drug
(Reuters) - A U.S. appeals court on Tuesday allowed generic drug company Dr. Reddy's Laboratories to sell a copycat version of the Indivior Plc opioid treatment Suboxone Film, sending Indivior's stock price down more than 40 percent.
Patient groups concerned over 'delay' in rare diseases treatment policy implementation
Patient's organisations on Tuesday sought immediate implementation of the National Policy for Treatment of Rare Diseases, stating the affected affected were losing lives due to "delayed response" from the government. The policy was approved by the Union Health Ministry in May last year, and the Rs 100-crore corpus that was allocated for it has lapsed, claimed an association of patients suffering from Lysosomal Storage Disorders (LSDs). Several children have lost their lives due to lack of treatment, the Lysosomal Storage Disorders Support Society (LSDSS) said, and claimed that recently a letter was sent to the health ministry, but there was no response. "Patients are losing lives as the government delays response. We had written a letter to a joint secretary in the health ministry, seeking a response on the initiation of treatment based on applications submitted by patients under the National Policy for Treatment of Rare Diseases. But there was no response," LSDSS president Manjit ...
Big pharma leaves big gaps: drugmakers urged to do more for poor
LONDON (Reuters) - Many of the world's top drugmakers are not doing enough to provide medicines to poor countries, leaving big gaps in access to treatments in crucial disease areas, including cancer, according to a new report on Tuesday.
Dr Dixit appointed ambassador of Maha's anti-obesity campaign
The Maharashtra government has appointed Dr Jagannath Dixitas the brand ambassador of its anti-obesity campaign. A letter to this effect was given to Dr Dixit by Medical Education Minister Girish Mahajan, an official release issued here said. The letter states that Dr Dixit has been appointed due to his experience and knowledge in the field . The method, he had adopted to treat patients has benefited people not just in India, but oversees as well. Dr Dixit is attached to the Government Medical College, Latur as a professor. Dr Dixit had started a WhatsApp group in 2012 to address the issue of obesity and provided guidance to people affected by the lifestyle disease.
Depression linked to increased risk of irregular heartbeat: Study
Depressed people could be at an increased risk of developing irregular heartbeat, says a study.
World's first total-body scanner produces 3D human images
The world's first medical imaging scanner that can capture a 3D picture of the whole human body at once in as little as 20-30 seconds, has produced its first scans, scientists said Monday. Developed by scientists from the University of California - Davis in the US, EXPLORER is a combined positron emission tomography (PET) and X-ray computed tomography (CT) scanner that can image the entire body at the same time. Since the machine captures radiation far more efficiently than other scanners, EXPLORER can produce an image in as little as one second and, over time, produce movies that can track specially tagged drugs as they move around the entire body. The technology will have countless applications, from improving diagnostics to tracking disease progression to researching new drug therapies, researchers said. EXPLORER will have a profound impact on clinical research and patient care because it produces higher-quality diagnostic PET scans than have ever been possible, they said. It also .
Hospitals, insurance providers may be leaking your data
More than hackers trying to breach your personal data, hospitals, doctors' offices and even insurance companies could be leaking out your identity, new research shows.
Alembic gets USFDA nod for erectile dysfunction drug
Alembic Pharmaceuticals Tuesday said it has received approval from the US health regulator to market Vardenafil Hydrochloride orally disintegrating tablets, used to treat erectile dysfunction. The company has received nod from the US Food & Drug Administration (USFDA) to market the drugm, which is therapeutically equivalent to Bayer Healthcare Pharmaceuticals's Staxyn, Alembic said in a regulatory filing. The company had previously received tentative approval for this product from the USFDA. According to IQVIA, Hydrochloride orally disintegrating tablets have an estimated market size of USD 8 million for twelve months ending December 2017. Alembic said it has now has a total of 78 abbreviated new drug application (ANDA) approvals from the US health regulator. Shares of Alembic Pharmaceuticals Tuesday ended 0.86 per cent up at Rs 567.45 on the BSE.
World's first total-body scanner produces incredible 3D images
The world's first medical imaging scanner that can capture a 3D picture of the entire human body at once in as little as 20-30 seconds has produced its first scans, say scientists, noting that the technology can aid in improving diagnostics to tracking disease progression to researching new drug therapies.
ImpactGuru.com achieves milestone of new crowdfunding record
ImpactGuru.com, India's largest crowdfunding platform for medical causes, witnessed a milestone after raising Rs. 45 lakhs in 7 days for a Mumbai based resident admitted at Apollo Hospitals Navi Mumbai.The patient, who was diagnosed with Acute Myeloid Leukemia (blood cancer) and was recommended by Dr. Punit Jain, Haemato Oncology & Bonemarrow Transplant Physician, was supported by Apollo Hospitals, given the strategic partnership by both parties announced earlier this year."When I put up the fundraiser, I did not have any expectations. I received so many calls, messages and well wishes. We have never ever seen such a huge response where people come out wholeheartedly on their own. There are good people around and we should not lose hope. We are eternally indebted to each and every one of you. Thank you so much for all the contributions," said Gopi Shenoy."Our partnership with ImpactGuru.com is towards the objective that no patient should be denied access to care - we are glad that
Antimicrobial Stewardship guidelines for judicious use of antibiotics released
To ensure judicious use of antibiotics in healthcare facilities, the ICMR released on Tuesday Antimicrobial Stewardship Guidelines to advise hospitals in setting up Antimicrobial Stewardship Programmes (AMSP) for the purpose. Antimicrobial resistance (AMR) is a major public health challenge, and with very few new antibiotics in the pipeline, it is important to use the existing drugs judiciously. Since inappropriate use of antibiotics is rampant in India, there is an urgent need to improve antibiotic use in hospitals, which can be achieved through implementation of good AMS programmes, Director General of the Indian Council of Medical Research (ICMR) Dr Balram Bhargava said. AMS guidelines provide guidance in setting up structure and processes of AMSP in healthcare institutions, discusses essential elements of antimicrobial stewardship and diagnostic stewardship, and provides information on tools that can be used to measure progress. The National Health Policy, 2017, terms ...
Leading French Medical Device Maker Pters Surgical Launches 'Make in India'
/ -- Inaugurates its new production site in Manesar, Haryana Following suit with Prime Minister Narendra Modi's 'Make in India' initiative, Pters Surgical, the leading French medical device manufacturer, today inaugurates its new site in Manesar, Haryana. Expanding its expertise into developing, manufacturing and marketing of single-use medical devices for operating room, the opening of this brand new facility will contribute greatly in improving the quality of patient care and contribute to the success of surgical procedures by developing high-performance medical devices in India. Spread across 17,000 square feet area, the Manesar site will be essential in moving up the quality scale of our needles workshop along with increasing our production capacity. Furthermore, a new clean room with ISO 8 ground floor will be operational by 2020. Designed to manufacture world-class medical devices, the facility will adopt an environment friendly approach, with the use of solar panels for power ..
New drug may help treat peanut allergy: Study
A novel oral immunotherapy drug -- derived from peanut protein -- could help treat people who are allergic to the nut, a study has found. Controlled ingestion of peanut protein could help build tolerance in peanut allergy sufferers, researchers said. "The results of this landmark trial are likely to lead to the first FDA-approved treatment for food allergy in 2019," said Christina Ciaccio, an associate professor at University of Chicago in the US. Researchers in 10 countries across North America and Europe conducted the trial, known as the Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization trial (PALISADE). Of 496 eligible participants ages 4 to 17, 372 received the AR101 oral medication, while the remainder received a placebo drug. At the end of the trial, more than two-thirds of the group taking the active drug were able to tolerate a dose of peanut protein equivalent to about two peanut kernels. According to the study, oral immunotherapy for peanut allergy has ...
First-ever drone-delivery of kidney yields promising results
Drone delivery may have tons of practical use cases but it is yet to be adopted for commercially. However, that does not stop people from experimenting with drone delivery. In the latest, researchers tested drone delivery of human kidney to see if the method is viable for the time-sensitive task.The researchers at the University of Maryland conducted an experiment of flying the kidney around Baltimore in a refrigerated box attached to a DJI M600 drone. The organ was made to travel 14 separate missions of various distances and profiles with the longest being three miles with a top speed of about 67.6 km/h, TechCrunch reported.Biopsies of the kidney were conducted before and after the flights and it was found that no damage had been done to the organ despite the wind chill and heat from the motors, or maneuvers of the drone.Although this method of delivering organs immensely cuts down on the time taken to transport from one area to the other, it is yet to get the green flag from the ...
New treatment shows promise against peanut allergy
In a first, an oral immunotherapy drug derived from peanut protein could help build tolerance and eliminate potentially deadly reactions in children and adolescents with severe peanut allergies.
Depressed people may have poor blood flow
According to a recent study, depressed people have an increased risk of atrial fibrillation, or an irregular heart rate that commonly causes poor blood flow.Researchers at Aarhus University also found that medication was not responsible for the high frequency of atrial fibrillation in depressed people. The findings are published in the European Journal of Preventive Cardiology."It is common knowledge that there is a connection between the mind and the heart. Depression predicts the development of coronary artery disease and worsens its prognosis. Our study investigated whether depression is also linked with atrial fibrillation," said study's author Morten Fenger-Grøn.Atrial fibrillation is the most common heart rhythm disorder (arrhythmia). It causes 20-30 per cent of all strokes and increases the risk of dying prematurely. It is estimated that by 2030 there will be 14-17 million patients with atrial fibrillation in the European Union, with 120,000-215,000 new diagnoses each ...
Psoriasis can put you at type 2 diabetes risk
According to a recent study, psoriasis and other inflammatory skin disorders could increase the risk of type 2 diabetes.The findings, which were presented at the Society for Endocrinology annual conference in Glasgow, indicate that improving skin health could be of major importance for the control of blood sugar and lowering diabetes risk.Approximately 2-3 percent of the global population suffers from psoriasis, a chronic inflammatory disorder where the immune system attacks skin cells, resulting in too much growth of younger skin cells leading to itchy red sores. Unfortunately, there is currently no cure for psoriasis with patients having to use treatments to alleviate the symptoms throughout their life.To add to this burden, previous studies have shown that having psoriasis increases your risk of developing type-2 diabetes. However, the specific biological mechanisms linking the two disorders are unknown, and if defined, they could lead to new therapies to treat patients suffering ..